Hematology Conferences 2021 | Blood disorders Congress | Hematology Congress | Hematologic diseases Meetings

Theme: Understand the pathophysiology of hematologic diseases & improve their outcomes

Hematology Congress

Scientific Program

Renowned Speakers

Jean-Francois Schved
Montpellier University
France

Wassil Nowicky
Ukrainian Anti-Cancer Institute
Australia

Gordon Moffat
SUNY Downstate Medical Center College of Medicine
USA

Michael Retsky
Harvard TH Chan School of Public Health
USA

Vanessa Bellat
Weill Cornell Medicine
USA

Porunelloor A. Mathew
University of North Texas Health Science Center
USA

Melvin L DePamphilis
National Institute for Child Health & Human Development
USA

Gaiane M. Rauch
University of Texas Cancer Center
USA

Zahra Mozaheb
Mashhad University of Medical Science
Iran

Xudong Miao
Zhejiang University
China

M Dahmani Fathallah
Arabian Gulf University
Bahrain

Rouslan Kotchetkov
University of Toronto
Canada

Natalia Neparidze
Yale School of Medicine
USA

Emmanuel Kufre Uko
University of Calabar
Nigeria

Yi Ning
Johns Hopkins University School of Medicine
Uruguay

Soad K. Al Jaouni
King Abdulaziz University
Saudi Arabia

Abishek B Santhakumar
Central Queensland University
Australia

Aamir Ahsan
McLaren Regional Medical Center
USA

Annie Viallat
University Aix-Marseille
France

Elena Zakharova
Botkin Memorial Teaching Hospital
Russia

Hematology Congress

Hematology Congress 2021 committee is overwhelmed to welcome you to join the upcoming European Virtual Congress on Hematology on June 14-15, 2021 via Webinar. The webinar is predicted to be best global platform for all the scientists, hematologists, oncologists, pathologists, surgeons, nurses, research scholars, business professionals, and students to discuss and learn about hematology. The webinar incorporates speaker oral talks, keynote presentations, poster displays, workshops and exhibitions. This committee will be organizing webinars by offering virtual platform to all researchers and associations in which webinars will be scheduled on wide range of topics emerging in Hematology and treatment for Hematologic Disorders and also advanced methodology for Diagnostics etc.

Conferenceseries LLC Ltd through its international conferences provides a best opportunity for the young researchers and scientists through its special initiatives like Poster Presentation, Young Researcher Forum, E-poster, B2B and Scientific Meetings and Live Streaming.

This webinar is best platform to discuss and learn about Hematology, Hematologic Oncology, Blood Disorders, Hematologic Disorders, Blood Disorders: Diagnosis & Treatment, Clinical and Experimental Hematology, Hematopathology, Pediatric hematology, Hematology Nursing, Immunohematology, Stem Cell Research and much more.

Hematology mainly concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. Blood Disorders can affect one or more specific parts of the blood and prevent blood from doing its functions. They may be acute or chronic.

Why to attend our Hematology Virtual Congress 2021

Hematology Virtual Congress 2021 will provide a scientific environment and a best dias for the participants to exchange their views and ideas regarding Hematology. Hematology field researchers and Associations from around the world focused on learning about Leukemia, Hemophilia, Blood clotting and Hematologic Oncology. It is a great chance to reach a huge assemblage of participants from the Hematology community to fight against these deadly disorders. This gathering will consolidate the feature of momentum advancements in the field of Medical Science in its battle against wellbeing perils.

Target Audience:

Hematologists
Oncologists
Hemato-pathologist
Scientists
Young Researchers
Medical Students
Physicians/Consultants/ General Practitioners
Nurses
Residents
Directors/Managers
Pathologists
Business Entrepreneurs
Hematology Pharma Companies
Medical Devices Companies
Hematology Associations/ Societies

Track-1: Blood and Hematology

The word Heme came from Greek which means blood. Hematology involves the diagnosis and treatment of patients who have disorders of the blood and bone marrow. It is mainly responsible for the diagnosis of benign and malignant disorders of the red and white blood cells, platelets and the coagulation system in adults and children. Blood disorders are conditions that impact the blood's ability to function correctly; their patients may have a serious life- threatening illness such as leukemia, lymphoma or myeloma that requires chemotherapy.

fig: Blood and Hematology

Track-2: Hematologic Malignancies

Hematology oncology is the most important part of Hematology research, a major part of blood based researches is carried out in this field. The cancer which originates from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases are treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell is called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myeloma.

fig: Hematologic Malignancies

Track-3: Blood Transfusion

Blood transfusion is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anemia, leukemia, and sickle cell disease. Transfusion may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Research and Development in this area of Hematology is hence considered a very important aspect.

fig: Blood Transfusion

Track-4: Disorders of Vascular Bleeding

Haemorrhage disorders are incited by vascular malformation or deficiency. They are linked with cutaneous or mucosal flat or perceptible purpura. These disorders are a heterogeneous assembly of circumstances categorized by easy staining, petechiae, mucosal bleeding, bruise, and impulsive hemorrhage from small vessels. The fundamental imperfection is stated to be moreover in the vessels themselves or in the perivascular connective tissue. The commonly used purpura usually describes subcutaneous bleeding, which will be linked to vessel wall abnormalities or platelet abnormalities of which some are hereditary and while the others are acquired.

fig: Vascular Bleedind Disorders

Track-5: Bio markers in Hematology and Oncology

Biomarkers are the biological molecules found in blood, other body fluids, or tissues, which explains a symbol of a normal or anomalous progression, or of a condition or illness. These are used to see how well the body answers to a therapy for an illness or disorder. These are also defined as molecular marker and signature molecule. A cancer biomarker is a gene or substance that detects the occurrence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.

fig: Biomarkers in Hematology and Oncology

Track-6: New Drug discovery in Hematology

Currently pharmaceutical firms are involved in the main specializing in Recombinant, genetically engineered pharmaceuticals which may be smart alternative for treatment. If you have got a gentle form of hemophilia, a medicine referred to as desmopressin acetate (DDAVP) will briefly increase the concentration of factor VIII in your blood. DDAVP may be given intravenously, through an injection, or within the type of nasal spray. Antifibrinolytic medicines like tranexamic acid and epsilon aminocaproic acid are that are typically used with replacement therapy to assist keep blood clots from breaking down.

fig: New Drug Discovery in Hematology

Track-7: Blood Disorders

Blood disorders affect one or more parts of the blood and prevents blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet. Types of blood disorders include Platelet disorders, excessive clotting, and bleeding problems, anemia, leukemia , myeloma and eosinophilic disorders.

fig: Blood Disorders

Track-8: Hematology-Oncology

Hematology-oncology is the science applied to treat blood disorders and diseases like cancers (oncology). Also, it treats with blood cancers and some disease includes iron deficiency anemia, thalassemia’s as well other organ cancers. The treatment will vary for individual suffering with myeloma based on many factors, in this multiple myeloma it includes a stage referred smoldering stage in which it doesn’t show active symptoms that is the state in which myeloma cells present in the body were not progressive.

fig: Hemayology-Oncology

Track-9: Clinical and Experimental Hematology

Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields: clinical chemistry, hematology, immunology, oncology and virology. The major criteria for publication will be clarity, experimental soundness and advances in knowledge. Papers containing new clinical or experimental data, are likely to contribute to changes in clinical practice in thinking about a disease will be given priority due to their immediate importance.

fig: Clinical and Experimental Hematology

Track-10: Blood Tranplantation, Thrombosis and Hemostasis

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with nutrient-rich blood from the placenta. Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.

fig: Blood Transplantation,Thrombosis and Hemostasis

Track-11: Immunohematology

Immunohematology is referred to as blood managing an account also, is a branch of Hematology which contemplates antigen-counter acting agent responses and comparative wonders as they identify with the pathogenesis and clinical indications of blood issue. Individuals working in this field are noted to as an immuno-hematologist. Individuals may be vaccinated to RBCs due to earlier contact to RBCs of different people, as often as possible through pregnancy or transfusion.

fig: Immunohematology

Track-12: Various aspects of Hematology

Pediatric Hematology covers all aspects of pediatric hematology and oncology. It includes immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or hematopathologists.

fig: Various aspects of Hematology

Track-13: Hematologic Cancers

Hematologic cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. The bone marrow in which many white blood cells develop that leads to multiple myeloma.

fig: Hematologic Cancer

Track-14: Transfusion Medicines

Blood Transfusion is a medical practice where donated blood is transfused to a recipient. It is a lifesaving, benign procedure. These are wont to treat several medical conditions like iron deficiency Anemia, red blood cell ailment, severe haemorrhage generally from surgery, childbirth, or a significant fate. There will be reform of transfusion facilities for healthier effectiveness and repair delivery. The number of blood banks will drop, and high-volume, technically up-clambered central blood banks will function in their place to diminish the prices of procedure.

fig: Transfusion Medicines

Track-15: Cancer Genomics and Metabolomics

Cancer genomics is a sub-field of genomics that personifies cancer-linked or cancer associated genes. Whereas Metabolomics is the quantification of small molecules formed by metabolic progressions within a biological model. Metabolomics datasets contain a wealth of data that reflect the disease state and are consequent to both genetic variation and environment. Because cancer is a genomic disease, genomic profiling is an undeniably important tool for precision oncology.

fig: Cancer Genomics and Metabolomics

Track-16: Cord Blood Transplantation

One of three foundations of blood-forming cells used in transplants are Cord Blood whereas the other two bases are bone marrow and peripheral blood stem cells. Human cryopreserved CD34+ cells from cord blood, bone marrow, and Mobilized blood. CD34+ cells differentiate into all other white blood cells. The first successful cord blood transplant (CBT) was wiped out 1988 during a child with Fanconi Anemia. The theory of the learning is twofold unit umbilical cord blood transplantation in adults will relate to a one-year endurance rate of at least 40%.

fig: Cord Blood Transplantation

Track-17: Hematology-Diagnostics and Screening

The channel of medicine that perturbed with the learning of the origin, diagnosis, therapy and anticipation of diseases related to blood. The test center slog that goes into the study of blood is recurrently performed by a medical technologist or medical laboratory scientist. Treating of blood disorder may differ for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder.

fig: Hematogy- Diagnostics and Screening

Track-18: Molecular typing of Blood

Blood group antigens are polymorphic residues of protein or carbohydrate on the red cell surface. They can provoke an antibody response in individuals who lack them, and some antibodies can lead to hemolytic transfusion reaction or hemolytic disease of the fetus/newborn. Researchers have identified the molecular basis of many red cell blood group antigens, and an actively maintained database currently lists over 1,600 alleles of 44 genes.

fig: Molecular Typing

Track-19: Effect of Advanced Technologies on Blood Based Products

A blood substitute is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating with UV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion.

fig: Effect of Advanced Technologies on Blood Based Products

Track-20: Case reports and Epidemiology of Hem Oncology and Hematology

A case report is usually considered a kind of anecdotal proof and a peer-referee Open Access journal that publishes case reports and case series in all areas of hematology, including general hematology and oncology, with a specific focus on lymphomas and leukemia and usually considered as a kind of anecdotal proof and Open Access journal that publishes case reports and case series in all areas of hematology, including general hematology and oncology, with a specific focus on lymphomas and leukemia.

fig: Case Reports and Epidemiology of Hematology and Hem-Oncology

Track-21: Hematologic Therapies

The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, as well as related disorders of the blood, such as aplastic anemia and Myelodysplastic syndrome.

fig: Hematologic Therapies

Track-22: Neuro-Hematolgy

The crossing point amongst hematology and neurology is comprehensive, and neurological complications within the course of hematologic ailment are recurrent and diverse. Polycythemia, in which there are increased numbers of red blood cells with iron deficient. Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders.

fig: Neuro-hematology

Track-23: Digital Imaging in Hematology

Developments in electronic imaging, computers, and the Internet have given rise to in the speedy emergence of digital imaging in pathology. The Bloodhound system is an instrument that's designed to print blood onto a slide with a controlled method, automatically stain cells, perform a CBC with WBC differential, and locate WBCs by digital imaging, all in an analyser with a footprint of 42 inches. Digital Imaging works in daily routine for leukocytes in peripheral blood and other fluids, is reliable, accurate and displays a high blast cell sensitity.

fig: Digital Imaging in Hematology

Track-24: Hematology Nursing

Hematology medical attendants are the specialists in taking care of the patients with blood related infections. They realize patients' medical record , and that they will help the hematologist to analyse and treat the blood related illnesses. They can recommend the prescription as they know about the state of the condition. Keeping in mind the end goal to seek after the learning of hematology nursing, one must finish the recognition in nursing or four year college education in nursing and the massive feeling of certainty happens when they have the involvement in the particular field.

fig: Hematology Nursing

Track-25: Pediatric Hematology

Paediatric haematology is a branch of haematology dealing with the general haematological problems seen in neonates or paediatric patients. Other issues like blood counts, Polycythaemia, Neonatal anaemia, Anaemia of prematurity, hemolytic anemia within the neonate, Congenital red cell defects, acquired red cell defects, Hyper bilirubinemia, Congenital dyserythropoietic anaemia, Acquired red cell aplasia, Neutropenia, leukaemia etc are dealt under Paediatric Haematology.

fig: Pediatric Hematology

Advantages of Participating at our conference

The advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
Our robust online publicity attracts 30000+ users and 50000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
Meet and exchange ideas with hundreds of like-minded professionals who are leaders in Hematology.
All the conference participants will have a different excuse to participate at one-to-one meeting with eminent Speakers and renowned keynote speakers.
A unique opportunity to listen what the worldwide researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of Hematology.
Hematology Congress intensive conference schedule, you will access strategic gift planning knowledge and expertise that’s worth its weight golf form an impressive array of recognized professionals.
Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
Exposure to Symposia’s, Workshops on carrier development and Preconference workshops in all major countries
Nominations for Best Poster Award
Outstanding Young Researcher Award
Group Registration benefits

Benefits of Participation- Speaker

Worldwide acknowledgment of Researcher’s profile
Obtain professional development credits
Explore the best in Cutting edge Research
Make Lasting connections at Networking and Social Events
An opportunity to give One page advertisement in abstract book and flyers distribution which eventually gets 1 Million views and add great value to your research profile
Learn beyond your field of interest, a change to know more about the new topics and research apart from your core subject from Hematology.
We provide unique convergence of Networking, Learning and Fun into a single package

Benefits of Participation- Delegate

Professional Development –Uplift the knowledge and skills
Conference attendance inspires, rejuvenates, and energizes delegates
Your participation at our conference will be helpful for a new approach and ideology that can be utilized for the extending the outcome of companies or industries.
Opportunities to meet through online webinar for Hematology Congress researchers and experts of same field and share new ideas

Benefit of Participation- Sponsor

Exposure to the international atmosphere will increase the odds of getting new business
Opportunity to showcase the new technology, new products of your company, or the service your industry to a broad international participants.
World’s No. 1 platform to show case Hematology products.
Increase business by lead generation through our conference participants.
Build a successful business takes a lot of time, effort and drive, so it’s always good to have a network of colleagues and associates to draw energy from people who share a similar drive and objective.
Hematology conferences create opportunities for greater focus and reflection that could help you take your business to the next level.
Benchmarking key strategies for business and moving it forward
Get answers to your business questions and challenges from credible individuals at our conference
Real Benefits in New business-Many Organizations make deals and sign contracts at our Hematology Congress.
Promotional logo of your organization at our conference banner, website and other proceedings, branding and marketing material

Benefit of Association for Collaborators

No one in the world have this huge visitors towards Hematology, this is the best platform to showcase the society
Create long-lasting relationships with the peers
Promotional content and Logo of your Association at our conference banner, website and other proceedings, branding and marketing material will increase your subscribers/Members number by 40%.
Our event visibility to your Organization page can give a great impact for your association in the Global Market forum.
Your representatives can network with key conference delegates to update their knowledge and understanding of your organization and services.
Details will be incorporated with Hematology promotional materials like flyers, brochure, pamphlets, program which will be distributed to Hospitals, Universities, Society and Researchers

Market Analysis of Hematology

The Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers ,Hemostasis, Immunohematology],Government labs, Price Range – Global Forecast to 2025" is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9% during the forecast period. The increasing of blood disorders and growth in the number of blood donation are the major factors for the growth of the global hematology analyzers and reagents market. Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period.

Hematology Virtual Congress 2021 accredit to increase the best stage for the aptitudes, explorations, specialists and company ambassadors with its well-planned plug-in covering every moment vision regarding medicine and blood syndromes from the derivation causes behind blood ailments to the foremost best remedies in treating blood disorders and diseases this congress is to relinquish a revolution for innovative defence against endless disorders like Thalassemia’s, lymphomas, biomarkers in blood and counter acting agents and substance responses and to look at the medical specialty chattels of blood which provides acquaintance regarding the foundation origins.

By end user, the hematology analyzers and reagents market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market due to factors such as the increasing awareness about hematology testing, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals

The global hematology market size is valued at US$ 4537.5 million in 2019, and is expected to exhibit a CAGR of 7.80% over the forecast period (2019–2024). Rising incidence of blood cancer is a major factor contributing to growth of the market.

Prevalance Of Anaemia

Blood disorders have become a global health issue and are associated with high mortality. Blood disorders, such as anemia, hemorrhagic conditions, blood infections and blood cancer , affect millions of people each year across all age groups. According to WHO, hemoglobin disorders are potentially affecting 75% of births, globally, and sickle cell trait affects an estimated one in 12 African Americans. Over 70% of all sickle-cell affected births occur in Africa. As per the World Health Organization, the prevalence of anemia in children is 47.4% and 12.7% in men, and it is increasing rapidly all over the world. According to the National Institute of Health (NIH), anemia affects 29% of women with reproductive age and 38% of pregnant women, worldwide.

Top Hematology Hospitals

Centro Médico Quironsalud Teknon
Anadolu Medical Center
Kardiolita Hospital
Sant Joan de Déu-Barcelona Children’s Hospital
Hospital Quirónsalud Marbella
Istanbul Memorial Hospital
Hospital Universitario HM Montepríncipe
Hospital Quirónsalud MalagaGrupo Hospitalario Quirónsalud
Quironsalud
Akh Vienna General Hospital
Teknon Medical Center
The London Clinic

Top Associations/Societies world-wide

American Society Of Hematology
British Society for Hematology
European Hematology Association
Multiple Myeloma Research Foundation
Myelodysplastic Syndromes Foundation
European Society for Radiotherapy and Oncology
International Society for Radiation Oncology
American College of Surgeons
Association of Cancer Surgery
European Society of Surgical Oncology
Society of Surgical Oncology

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 14-15, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

European Virtual Congress on Hematology June 14-15, 2021 Chicago, USA

Recommended Global Hematology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Hematology Congress

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues